AtkinsRéalis signs nuclear collaboration agreement with France's EDF
MONTREAL – Engineering firm AtkinsRéalis Group Inc. has signed a nuclear collaboration with Électricité de France.
The company says the agreement with the French company expands an existing partnership in an effort to work together to respond to new nuclear reactor opportunities around the world.
The deal includes potential collaboration on engineering support, equipment, operations, installation and commissioning, and co-operation between the global technology centres of both organizations.
It also includes potential collaboration around waste management and fuel production.
The companies will continue to compete on reactor technology vendor selection processes where appropriate.
AtkinsRéalis's nuclear business includes its Candu Energy Inc. subsidiary.
Monday Mornings
The latest local business news and a lookahead to the coming week.
This report by The Canadian Press was first published June 9, 2025.
Companies in this story: (TSX:ATRL)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
2 hours ago
- Globe and Mail
MedX Announces Final Closing of Non-Brokered Private Placement
MedX Health Corp. (' MedX ' or the ' Company ') (TSX-V: MDX) is pleased to announce that, further to its Press Releases dated April 7, and May 22, 2025, announcing an Initial Closing and further Closing, it has completed a final Closing of the Non-brokered Private Placement to accredited investors originally announced in its Press Release dated February 25, 2025. The Final Closing comprised the issuance of 8,678,571 Units (as described below) and raised cash proceeds of $607,500, bringing the total amount raised in the Placement to $2,063,500. Securities issued are subject to a regulatory 'hold' period of four months and one day from the date of issuance. Under this Non-Brokered Private Placement, the Company issued a total of 29,478,571 Units at $0.07 per Unit ('Unit'). Each Unit is comprised of One (1) fully paid common share and One (1) Share Purchase Warrant (' Warrant ( s)'), exercisable to purchase One (1) further Common Share at the price of $0.09, during the period of one year commencing on the date of issuance. Three Insiders participated in this Placement to the extent of $500,000, for the acquisition of a total of 7,142,857 Units. In connection with the issuance of Units to those Insiders, the Company relies on exemptions from formal valuation and minority shareholder approval requirements set out in Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (' MI 61-101 '). as (i) the fair market value of the proposed placement to the Insiders does not exceed 25% of the market capitalization of the Company and (ii) the conditions in section 5.7(1)(a), section 5.7(1)(b) and section 5.7(1)(e) of MI 61-101 are met. Qualified agents received total cash commissions of $15,880, (equal to 8% of the gross proceeds received by the Company from the sale of the Units to subscribers introduced by such agent(s)), and 226,857 agent's warrants (' Agent's Warrant(s) ') (equal to 8% of subscriptions introduced by such agent(s)). Each Agent's Warrant, which is non-transferable, entitles the holder to acquire, at the price of CAD$0.07, a unit, comprised of One (1) fully paid Common Share and one (1) non-transferable share purchase warrant (' Agent's Share Purchase Warrant '), entitling the holder to acquire one additional Common Share at the price of CAD$0.09. The Agent's Warrants and any Agent's Share Purchase Warrants that may be issued pursuant to exercise of an Agent's Warrant, if not exercised, will expire one year following the date of issuance. Funds raised in this Placement are being be directed towards continuing development of the Company's leading edge SIAscopy® on DermSecure® telemedicine platform, building out the launch of its technology into the occupational health marketplace, and general corporate purposes. About MedX Health Corp.: MedX, headquartered in Ontario, Canada, is a leading medical device and software company focused on skin health with its SIAscopy® on DermSecure® telemedicine platform, utilizing its SIAscopy® technology. SIAscopy® is also imbedded in its products SIAMETRICS®, SIMSYS®, and MoleMate®, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS®, SIMSYS®, and MoleMate® include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are cleared by Health Canada, the U.S. Food and Drug Administration, the Therapeutic Goods Administration and Conformité Européenne for use in Canada, the U.S., Australia, New Zealand, the European Union and Turkey. Visit This Media Release may contain forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties.
Cision Canada
3 hours ago
- Cision Canada
ANNUAL GENERAL MEETING
VANCOUVER, BC, June 9, 2025 /CNW/ - (TSX: AOI) (Nasdaq-Stockholm: AOI) – Meren Energy Inc. ("Meren" or the "Company") confirms that its Annual General Meeting of Shareholders will be held on Thursday, June 12, 2025 at 09:00 am (Pacific Time) at Bennett Jones LLP Fraser Boardroom, Park Place, 666 Burrard Street, Suite 2500, Vancouver V6C 2X8. View PDF version The purpose of the Meeting is as follows: View PDF To receive the consolidated audited financial statements and accompanying management's discussion and analysis of the Company for the year ended December 31, 2024, together with the report of the auditors; To appoint PricewaterhouseCoopers LLP as auditors of the Company to hold office until the next Annual General Meeting, at a remuneration to be fixed by the directors of the Company; To consider and, if deemed advisable, to approve an advisory resolution to accept the Company's approach to executive compensation; and To elect directors to hold office for the ensuing year. The record date for the Annual General Meeting of Shareholders is April 24, 2025. The Notice of Meeting, Management Information Circular, and related meeting materials are available under the Company's profile on SEDAR at and on the Company's website at About Meren Meren is a full-cycle Independent upstream oil and gas company with interests offshore Nigeria, Namibia, South Africa and Equatorial Guinea. Its main assets are producing and development assets in deepwater Nigeria operated by Majors. The Company holds a leading position in the Orange Basin including its effective interest in the Venus light oil project, offshore Namibia, and its direct interest in Block 3B/4B, offshore South Africa. Additional Information This information was submitted for publication, through the agency of the contact persons set out above, at 6:30 p.m. EDT on June 9, 2025. Forward Looking Information Certain statements and information contained herein constitute "forward-looking information" (within the meaning of applicable Canadian securities legislation). Such statements and information (together, "forward-looking statements") relate to future events or the Company's future performance, business prospects or opportunities. All statements other than statements of historical fact may be forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as "seek", "anticipate", "plan", "continue", "estimate", "expect, "may", "will", "project", "predict", "potential", "targeting", "intend", "could", "might", "should", "believe" and similar expressions) are not statements of historical fact and may be "forward looking statements". SOURCE Meren Energy Inc.
Cision Canada
3 hours ago
- Cision Canada
STAR DIAMOND CORPORATION ANNOUNCES DATE OF SPECIAL MEETING OF SHAREHOLDERS AND CONVERSION OF PROMISSORY NOTES
SASKATOON, SK, June 9, 2025 /CNW/ - Star Diamond Corporation (the "Company") (TSX: DIAM) is pleased to announce that, further to the Company's press release issued on May 16, 2025, a special meeting of the Company's shareholders will be held on July 29, 2025 (the "Meeting"). Only persons registered as holders of common shares of the Company ("Common Shares") as of the close of business on June 13, 2025 are entitled to receive notice of and to vote at the Meeting. The Meeting is being held in connection with the previously announced proposed private placement of units of the Company to Spirit Resources s.a.r.l. ("Spirit") for gross proceeds of Cdn. $4,000,000 (the "Private Placement"). At the Meeting, holders of Common Shares will be asked to, among other things, approve: (i) the waiver of the application of the Company's Amended and Restated Shareholder Rights plan dated May 30, 2023 (the "Shareholder Rights Plan") to the Private Placement and the termination of the Shareholder Rights Plan; (ii) the issuance of Common Shares and Common Share purchase warrants on the terms of the Private Placement, including the Private Placement materially affecting control of the Company; (iii) the election of two individuals nominated by Spirit to the board of directors of the Company in connection with the completion of the Private Placement; and (iv) any such other matters as may be agreed by the Company and Spirit. The Company also announces that it has issued an aggregate of 3,399,817 Common Shares (the "Conversion Shares") at a price of $0.045 per Conversion Share upon the voluntary conversion of existing convertible promissory notes of the Company issued on February 27, 2025 (the "Promissory Notes"). The issuance is in full satisfaction of principal and interest in the aggregate amount of Cdn. $152,991.78 due under the Promissory Notes. The Conversion Shares are subject to a statutory hold period expiring on June 28, 2025. Unless voluntarily converted prior to the completion of the Private Placement, the completion of the Private Placement would trigger the automatic conversion of the balance of the principal and interest then due under the Promissory Notes in accordance with the terms of the Promissory Notes. The offer and sale of the securities offered in the Offering has not been and will not be registered under the US Securities Act of 1933, as amended, or any state securities laws, and such securities may not be offered or sold in the United States absent registration or applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any jurisdiction in which the offer, sale or solicitation would be unlawful. This news release does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities, in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended, or any state securities laws, and may not be offered or sold within the United States unless an exemption from such registration is available. About Star Diamond Corporation The Company is a Canadian-based corporation engaged in the acquisition, exploration and development of mineral properties. Shares of the Company trade on the Toronto Stock Exchange under the trading symbol "DIAM". The Company's most significant asset is its interest in the Fort à la Corne property in central Saskatchewan. These diamondiferous kimberlites are located in close proximity to established infrastructure, including paved highways and the electrical power grid, which provide significant advantages for future mine development. CAUTION REGARDING FORWARD-LOOKING INFORMATION This press release contains "forward-looking statements" and/or "forward-looking information" (collectively, "forward-looking statements") within the meaning of applicable securities legislation. All statements, other than statements of historical fact, are forward-looking statements. The use of any of the words "anticipate", "plan", "aim", "target", "contemplate", "continue", "estimate", "expect", "intend", "propose", "might", "may", "will", "shall", "project", "should", "could", "would", "believe", "predict", "forecast", "pursue", "potential", "possible", "capable" and similar expressions are intended to identify "forward-looking statements. Forward-looking statements in this press release include, but are not limited to, expectations regarding the completion of the Private Placement, including with respect to obtaining shareholder and regulatory approvals in connection therewith, and the resulting automatic conversion of the Promissory Notes. These forward-looking statements are based on the Company's current beliefs as well as assumptions made by and information currently available to it and involve inherent risks and uncertainties, both general and specific. Risks exist that forward-looking statements will not be achieved due to a number of factors including, but not limited to, the receipt of applicable shareholder and regulatory approvals, availability of financing, the impact of changes in the laws and regulations regulating mining exploration, development, closure, judicial or regulatory judgments and legal proceedings and the additional risks described the Company's most recently filed Annual Information Form, and annual and interim MD&A. Although management of the Company considers the assumptions contained in forward-looking statements to be reasonable based on information currently available to the Company, those assumptions may prove to be incorrect. When making decisions with respect to the Company, investors and others should not place undue reliance on these statements and should carefully consider the foregoing factors and other uncertainties and potential events. The Company does not undertake any obligation to release publicly revisions to any forward-looking statement to reflect events or circumstances after the date of this release, or to reflect the occurrence of unanticipated events, except as may be required under applicable securities laws. Investors should not assume that any lack of update to a previously issued forward-looking statement constitutes a reaffirmation of that statement. Continued reliance on forward-looking statements is at investors' own risk.
